Risk factors for linezolid-associated hyponatremia focused on differences between intravenous and oral administration: a single-center, retrospective study
Abstract Background Linezolid (LZD)-associated hyponatremia is a rare side effect, and no reports have compared intravenous and oral administration in relation to the development of hyponatremia. This study aimed to identify risk factors for LZD-associated hyponatremia and to evaluate whether there...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-06-01
|
| Serija: | Journal of Pharmaceutical Health Care and Sciences |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s40780-025-00463-0 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
